New Oral Cholera Vaccine ‘HILLCHOL’ by Bharat Biotech Tackles Global Deficit
August 28, 2024: Bharat Biotech International Limited (BBIL) announced the launch of HILLCHOL® (BBV131), a novel single-strain Oral Cholera Vaccine (OCV). The OCV was developed by Bharat Biotech under license from Hilleman Laboratories (funded by Merck, USA and Wellcome Trust, UK), to combat cholera, a significant advancement in global health. Currently, only one manufacturer supplies […]
New Oral Cholera Vaccine ‘HILLCHOL’ by Bharat Biotech Tackles Global Deficit Read More »